That will only happen with increasing revenue from treatments being positively shown. I agree with 65Vette in that this quarter's numbers may be pleasing to us, but we still will have to wait until the following to see if an upward trend in revenue can be sustained to attract the interest that we are seeking that will drive the price back towards .50, .70, .77 and then maybe on to a buck.
News 
Market Data 
Discover 
